Analysts’ Viewpoint
Congenital heart defects are structural abnormalities of the heart that are present at birth. Increase in the prevalence of congenital heart disease is driving the pediatric perfusion products market size.
Growth in the number of surgical procedures performed on children is expected to augment market progress during the forecast period. Several surgical procedures are becoming available for the treatment of a wider range of conditions in children, as medical technologies continue to advance.
Rise in awareness about heart abnormalities and related treatments is likely to offer lucrative growth opportunities for vendors in the market. Therefore, vendors are focused on the approval and launch of new products to expand their pediatric perfusion products market share.
Pediatric perfusion deals with the circulatory and respiratory needs of children during open-heart surgery. Pediatric perfusion devices are used to support the circulation and oxygenation of a child's blood during surgery. These devices ensure that the child's vital organs receive oxygen and nutrients during a surgical procedure.
Pediatric perfusion devices play a crucial role in the treatment of various congenital heart defects. These defects can range from mild to severe and can require surgical intervention. Heart-lung machines and oxygenators, blood pumps, cardiac monitors, and pediatric cannula are various types of pediatric perfusion products available in the industry.
Changes in individual genes or chromosomes can increase the risk of cardiac birth defects in children. Ventricular Septal Defect (VSD) is a common congenital heart defect in children. According to the Centers for Disease Control and Prevention (CDC), 16,800 infants in the U.S. are born with VSD.
Additionally, one million children suffer from congenital heart defects. This is anticipated to aid pediatric perfusion products market expansion in the near future.
Vendors in the industry are investing significantly in the R&D of pediatric perfusion technology. New products are being developed that offer better performance and more advanced features. These products can provide more effective support to children during surgical procedures.
In April 2021, LivaNova PLC received the U.S. Food and Drug Administration (FDA) 510(k) clearance for B-Capta, the new in-line, blood-gas monitoring system integrated into the market-leading S5 heart-lung machine. Thus, approval and launch of new products is estimated to fuel market statistics in the near future.
According to the latest market trends, the pediatric cannulae product segment is anticipated to hold largest share during the forecast period. This can be ascribed to increase in the prevalence of respiratory diseases in newborns and surge in preference for cannulae. Pediatric cannulae are soft and flexible, which make them suitable for neonatal use in high-flow oxygen therapy.
The hospitals end-user segment held highest share of the market in 2021. The segment is expected to grow at a significant CAGR during the forecast period. Robust hospital infrastructure, increase in healthcare expenditure, and rise in the volume of surgeries due high prevalence of congenital heart diseases are driving the segment. Surge in the number of medical centers and operating rooms and high demand for cardiac surgeries are also fueling the segment.
According to the latest pediatric perfusion products market forecast, North America is projected to dominate the industry during 2022-2031. High prevalence of congenital heart diseases is driving market revenue in the region.
According to the CDC, congenital heart diseases affect approximately 1% of the total pediatric population in the U.S. each year. The prevalence of mild congenital heart diseases has increased in the country in the past five years, whereas the prevalence of severe congenital heart diseases has remained stable.
Increase in adoption of open heart surgeries, rise in the diagnosis rate of congenital heart diseases, and the presence of well-established healthcare infrastructure are also fueling pediatric perfusion products market development in North America.
According to the Cincinnati Children's Hospital Medical Center, more than 20,000 pediatric open heart surgeries are performed in the U.S. each year. The industry in Asia Pacific is projected to grow at the highest CAGR of 8.2% during the forecast period, owing to a large population of newborns and a surge in investment in the healthcare sector.
Major vendors in the industry have been profiled in the pediatric perfusion products market report based on parameters such as product portfolio, recent developments, financial overview, company overview, business strategies, and business segments.
These vendors include Medtronic, Terumo Cardiovascular Systems Corporation, LivaNova PLC, BL Lifesciences, Cardinal Health, Getinge AB, and Eurosets. These companies in the market are known for their high-quality products and innovative technologies.
Terumo Cardiovascular Systems Corporation is a global medical device company that offers a range of pediatric perfusion products, including heart-lung machines, oxygenators, and blood pumps. The company is known for its expertise in the field of pediatric perfusion. It is committed to improve pediatric care during surgery and invests significantly in the R&D of advanced products to achieve this goal.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 147.0 Mn |
|
Market Forecast Value in 2031 |
More than US$ 294.6 Mn |
|
Compound Annual Growth Rate (CAGR) |
7.3% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
It stood at US$ 147.0 Mn in 2021
It is projected to reach more than US$ 294.6 Mn by 2031
It is likely to be 7.3% from 2022 to 2031
Increase in prevalence of congenital heart disease and growth in number of surgical procedures performed on children
Medtronic, Terumo Cardiovascular Systems Corporation, LivaNova PLC, BL Lifesciences, Cardinal Health, Getinge AB, and Eurosets
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pediatric Perfusion Products Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pediatric Perfusion Products Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario
5.3. COVID-19 Pandemic Impact on Industry
6. Global Pediatric Perfusion Products Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Pediatric Oxygenators
6.3.2. Pediatric Arterial Filters
6.3.3. Pediatric Cannulae
6.3.4. Hemoconcentrators
6.3.5. Reservoirs
6.3.6. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Pediatric Perfusion Products Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Speciality Clinics
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Pediatric Perfusion Products Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Pediatric Perfusion Products Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2031
9.2.1. Pediatric Oxygenators
9.2.2. Pediatric Arterial Filters
9.2.3. Pediatric Cannulae
9.2.4. Hemoconcentrators
9.2.5. Reservoirs
9.2.6. Others
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Speciality Clinics
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Pediatric Perfusion Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Pediatric Oxygenators
10.2.2. Pediatric Arterial Filters
10.2.3. Pediatric Cannulae
10.2.4. Hemoconcentrators
10.2.5. Reservoirs
10.2.6. Others
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Speciality Clinics
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Pediatric Perfusion Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Pediatric Oxygenators
11.2.2. Pediatric Arterial Filters
11.2.3. Pediatric Cannulae
11.2.4. Hemoconcentrators
11.2.5. Reservoirs
11.2.6. Others
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Speciality Clinics
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Pediatric Perfusion Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Pediatric Oxygenators
12.2.2. Pediatric Arterial Filters
12.2.3. Pediatric Cannulae
12.2.4. Hemoconcentrators
12.2.5. Reservoirs
12.2.6. Others
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Speciality Clinics
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Pediatric Perfusion Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Pediatric Oxygenators
13.2.2. Pediatric Arterial Filters
13.2.3. Pediatric Cannulae
13.2.4. Hemoconcentrators
13.2.5. Reservoirs
13.2.6. Others
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Speciality Clinics
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2021)
14.3. Company Profiles
14.3.1. Medtronic
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Terumo Cardiovascular Systems Corporation
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. LivaNova PLC
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. BL Lifesciences
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Cardinal Health
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Getinge AB
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Eurosets
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
List of Tables
Table 01: Global Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 03: Global Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 05: North America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: North America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: Europe Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 08: Europe Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Asia Pacific Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 11: Asia Pacific Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: Asia Pacific Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 13: Latin America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 14: Latin America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 15: Latin America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Middle East & Africa Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 17: Middle East & Africa Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 18: Middle East & Africa Pediatric Perfusion Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Pediatric Perfusion Products Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Pediatric Perfusion Products Market Analysis and Forecast, by Product, 2021 and 2031
Figure 03: Global Pediatric Perfusion Products Market Attractiveness Analysis, by Product, 2022–2031
Figure 04: Global Pediatric Perfusion Products Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 05: Global Pediatric Perfusion Products Market Attractiveness Analysis, by End-user, 2022–2031
Figure 06: Global Pediatric Perfusion Products Market Analysis and Forecast, by Region, 2021 and 2031
Figure 07: Global Pediatric Perfusion Products Market Attractiveness Analysis, by Region, 2022–2031
Figure 08: North America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, 2017–2031
Figure 09: North America Pediatric Perfusion Products Market Analysis and Forecast, by Product, 2021 and 2031
Figure 10: North America Pediatric Perfusion Products Market Attractiveness Analysis, by Product, 2022–2031
Figure 11: North America Pediatric Perfusion Products Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 12: North America Pediatric Perfusion Products Market Attractiveness Analysis, by End-user, 2022–2031
Figure 13: North America Pediatric Perfusion Products Market Analysis and Forecast, by Country, 2021 and 2031
Figure 14: North America Pediatric Perfusion Products Market Attractiveness Analysis, by Country, 2022–2031
Figure 15: Europe Pediatric Perfusion Products Market Value (US$ Mn) Forecast, 2017–2031
Figure 16: Europe Pediatric Perfusion Products Market Analysis and Forecast, by Product, 2021 and 2031
Figure 17: Europe Pediatric Perfusion Products Market Attractiveness Analysis, by Product, 2022–2031
Figure 18: Europe Pediatric Perfusion Products Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 19: Europe Pediatric Perfusion Products Market Attractiveness Analysis, by End-user, 2022–2031
Figure 20: Europe Pediatric Perfusion Products Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 21: Europe Pediatric Perfusion Products Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 22: Asia Pacific Pediatric Perfusion Products Market Value (US$ Mn) Forecast, 2017–2031
Figure 23: Asia Pacific Pediatric Perfusion Products Market Analysis and Forecast, by Product, 2021 and 2031
Figure 24: Asia Pacific Pediatric Perfusion Products Market Attractiveness Analysis, by Product, 2022–2031
Figure 25: Asia Pacific Pediatric Perfusion Products Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 26: Asia Pacific Pediatric Perfusion Products Market Attractiveness Analysis, by End-user, 2022–2031
Figure 27: Asia Pacific Pediatric Perfusion Products Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 28: Asia Pacific Pediatric Perfusion Products Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 29: Latin America Pediatric Perfusion Products Market Value (US$ Mn) Forecast, 2017–2031
Figure 30: Latin America Pediatric Perfusion Products Market Analysis and Forecast, by Product, 2021 and 2031
Figure 31: Latin America Pediatric Perfusion Products Market Attractiveness Analysis, by Product, 2022–2031
Figure 32: Latin America Pediatric Perfusion Products Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 33: Latin America Pediatric Perfusion Products Market Attractiveness Analysis, by End-user, 2022–2031
Figure 34: Latin America Pediatric Perfusion Products Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 35: Latin America Pediatric Perfusion Products Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 36: Middle East & Africa Pediatric Perfusion Products Market Value (US$ Mn) Forecast, 2017–2031
Figure 37: Middle East & Africa Pediatric Perfusion Products Market Analysis and Forecast, by Product, 2021 and 2031
Figure 38: Middle East & Africa Pediatric Perfusion Products Market Attractiveness Analysis, by Product, 2022–2031
Figure 39: Middle East & Africa Pediatric Perfusion Products Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 40: Middle East & Africa Pediatric Perfusion Products Market Attractiveness Analysis, by End-user, 2022–2031
Figure 41: Middle East & Africa Pediatric Perfusion Products Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 42: Middle East & Africa Pediatric Perfusion Products Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 43: Global Pediatric Perfusion Products Market Share Analysis/Ranking, by Company, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Pediatric Perfusion Products Market
